Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antidepressive agents AND combination drug therapy AND depressive disorder AND double-blind method:

Search results

Items: 1 to 20 of 487

1.

Novel Augmentation Strategies in Major Depression.

Martiny K.

Dan Med J. 2017 Apr;64(4). pii: B5338. Review.

PMID:
28385173
2.

Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data.

Mizushima J, Uchida H, Tada M, Suzuki T, Mimura M, Nio S.

J Clin Psychiatry. 2017 Feb;78(2):e146-e151. doi: 10.4088/JCP.15m10573.

PMID:
28234437
3.

Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Roohi-Azizi M, Arabzadeh S, Amidfar M, Salimi S, Zarindast MR, Talaei A, Akhondzadeh S.

Clin Neuropharmacol. 2017 Jan/Feb;40(1):1-5. doi: 10.1097/WNF.0000000000000185.

PMID:
28085707
4.

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.

Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI.

J Clin Psychiatry. 2017 Apr;78(4):449-455. doi: 10.4088/JCP.15m10426.

PMID:
27835715
5.

Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.

Amidfar M, Khiabany M, Kohi A, Salardini E, Arbabi M, Roohi Azizi M, Zarrindast MR, Mohammadinejad P, Zeinoddini A, Akhondzadeh S.

J Clin Pharm Ther. 2017 Feb;42(1):44-50. doi: 10.1111/jcpt.12469. Epub 2016 Nov 3.

PMID:
27809351
6.

Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.

Amsterdam JD, Lorenzo-Luaces L, DeRubeis RJ.

Bipolar Disord. 2016 Nov;18(7):563-570. doi: 10.1111/bdi.12442. Epub 2016 Nov 2.

7.

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.

Quiroz JA, Tamburri P, Deptula D, Banken L, Beyer U, Rabbia M, Parkar N, Fontoura P, Santarelli L.

JAMA Psychiatry. 2016 Jul 1;73(7):675-84. doi: 10.1001/jamapsychiatry.2016.0838.

PMID:
27304433
8.

Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.

Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A.

BMC Psychiatry. 2016 May 23;16:157. doi: 10.1186/s12888-016-0865-y.

9.

Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials.

McIntyre RS, Weiller E, Zhang P, Weiss C.

J Affect Disord. 2016 Sep 1;201:116-23. doi: 10.1016/j.jad.2016.05.013. Epub 2016 May 12.

PMID:
27208498
10.

Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.

Suppes T, Kroger H, Pikalov A, Loebel A.

J Psychiatr Res. 2016 Jul;78:86-93. doi: 10.1016/j.jpsychires.2016.03.012. Epub 2016 Mar 31.

11.

Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.

Durgam S, Earley W, Guo H, Li D, Németh G, Laszlovszky I, Fava M, Montgomery SA.

J Clin Psychiatry. 2016 Mar;77(3):371-8. doi: 10.4088/JCP.15m10070.

12.

[Other therapeutic strategies].

Saba G, Nieto I, Bation R, Allaïli N, Bennabi D, Moliere F, Richieri R, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courtet P, Courvoisier P, Haesebaert F, Doumy O, El-Hage W, Garnier M, d'Amato T, Bougerol T, Lançon C, Haffen E, Llorca PM, Vaiva G, Bellivier F, Leboyer M, Aouizerate B.

Presse Med. 2016 Mar;45(3):350-9. doi: 10.1016/j.lpm.2016.02.005. Epub 2016 Mar 16. Review. French.

PMID:
26995510
13.

[Potentiation strategies].

Doumy O, Bennabi D, El-Hage W, Allaïli N, Bation R, Bellivier F, Holtzmann J, Bubrovszky M, Camus V, Charpeaud T, Courvoisier P, d'Amato T, Garnier M, Haesebaert F, Bougerol T, Lançon C, Moliere F, Nieto I, Richieri R, Saba G, Courtet P, Vaiva G, Leboyer M, Llorca PM, Aouizerate B, Haffen E.

Presse Med. 2016 Mar;45(3):338-49. doi: 10.1016/j.lpm.2016.02.004. Epub 2016 Mar 10. Review. French.

PMID:
26970936
14.

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Fava M, Memisoglu A, Thase ME, Bodkin JA, Trivedi MH, de Somer M, Du Y, Leigh-Pemberton R, DiPetrillo L, Silverman B, Ehrich E.

Am J Psychiatry. 2016 May 1;173(5):499-508. doi: 10.1176/appi.ajp.2015.15070921. Epub 2016 Feb 12.

PMID:
26869247
15.

Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder.

Yoon S, Kim JE, Hwang J, Kim TS, Kang HJ, Namgung E, Ban S, Oh S, Yang J, Renshaw PF, Lyoo IK.

Biol Psychiatry. 2016 Sep 15;80(6):439-447. doi: 10.1016/j.biopsych.2015.11.027. Epub 2015 Dec 15.

PMID:
26822799
16.

Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.

Salardini E, Zeinoddini A, Mohammadinejad P, Khodaie-Ardakani MR, Zahraei N, Zeinoddini A, Akhondzadeh S.

J Psychiatr Res. 2016 Apr;75:24-30. doi: 10.1016/j.jpsychires.2016.01.003. Epub 2016 Jan 7.

PMID:
26800392
17.

Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.

Chapel S, Chiu YY, Hsu J, Cucchiaro J, Loebel A.

Clin Ther. 2016 Jan 1;38(1):4-15. doi: 10.1016/j.clinthera.2015.11.013. Epub 2015 Dec 22.

18.

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.

McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BN, Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S; ADD Study Team.

Lancet Psychiatry. 2016 Feb;3(2):117-27. doi: 10.1016/S2215-0366(15)00436-8. Epub 2015 Dec 23.

PMID:
26727041
19.

Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.

Lin KW, Wroolie TE, Robakis T, Rasgon NL.

Psychiatry Res. 2015 Dec 30;230(3):846-52. doi: 10.1016/j.psychres.2015.10.013. Epub 2015 Oct 22.

20.

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.

Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Qurashi I, Khoso AB, Deakin JF, Husain N, Young AH.

Trials. 2015 Sep 15;16:410. doi: 10.1186/s13063-015-0933-5.

Supplemental Content

Loading ...
Support Center